NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.00
+0.31 (2.44%)
At close: Sep 18, 2025, 4:00 PM EDT
13.01
+0.01 (0.04%)
After-hours: Sep 18, 2025, 7:44 PM EDT
NovoCure Employees
NovoCure had 1,488 employees as of December 31, 2024. The number of employees increased by 35 or 2.41% compared to the previous year.
Employees
1,488
Change (1Y)
35
Growth (1Y)
2.41%
Revenue / Employee
$423,495
Profits / Employee
-$114,886
Market Cap
1.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,488 | 35 | 2.41% |
| Dec 31, 2023 | 1,453 | 133 | 10.08% |
| Dec 31, 2022 | 1,320 | 153 | 13.11% |
| Dec 31, 2021 | 1,167 | 144 | 14.08% |
| Dec 31, 2020 | 1,023 | 241 | 30.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVCR News
- 3 days ago - Novocure's Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC) - Business Wire
- 8 days ago - NovoCure Limited (NVCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 21 days ago - Novocure Announces Upcoming Investor Events - Business Wire
- 24 days ago - Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain - Business Wire
- 4 weeks ago - Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer - Business Wire
- 7 weeks ago - NovoCure's Wearable Oncology Edge And Compelling Valuation - Seeking Alpha
- 7 weeks ago - Top 3 Health Care Stocks That May Explode In July - Benzinga
- 7 weeks ago - NovoCure Limited (NVCR) Q2 2025 Earnings Call Transcript - Seeking Alpha